Mermaid Medical Group® Achieves Zero Non-Conformities in ISO 14001 Environmental Audit
Mermaid Medical Group® is proud to share that it has successfully passed its ISO 14001 audit with zero non-conformities identified.
Mermaid Medical Group® proudly welcomes Daniel Nilsson Lennartz as the new Business Development Director, effective September 1st, 2024. As one of the co-founders, Daniel brings invaluable insights and expertise that will continue to drive the company’s growth and long-term success.
Daniel has played a huge role in Mermaid Medical Group®'s growth, and we are thrilled that he has taken on the new responsibilities as Business Development Director. In this role, he will guide the expansion of our product portfolio, explore new business opportunities, and integrate advanced IT technologies to enhance our operations and efficiency.
With his strategic mindset, extensive industry knowledge, and passionate vision, we are confident that Daniel is the right person to tackle these exciting challenges.
With over 20 years of experience in healthcare and having been with the company since day one, Daniel has held several key roles that have profoundly shaped various aspects of the business. During his first decade with the company, he was key in establishing and nurturing our strategic partnerships. Daniel then transitioned to the field of Sales & Marketing, overseeing all sales and marketing initiatives across Europe. In his most recent position as Sales Director, Daniel was responsible for driving, coaching, and motivating our global sales teams, ensuring that targets were consistently met.
This strategic appointment of Daniel as Business Development Director positions Mermaid Medical Group for continued growth and success. It reflects our commitment to innovation, excellence, and strategic development—driving us forward to achieve our ambitious goals.
Mermaid Medical Group® is proud to share that it has successfully passed its ISO 14001 audit with zero non-conformities identified.
Mermaid Medical Group® is pleased to announce an exclusive distribution agreement with MicroPort® for two cardiovascular devices: the VitaFlow Liberty™ Aortic Valve & Delivery System and Anchorman™ for LAAC procedures.
Mermaid Medical Group is excited to introduce its latest product addition: the Full Core Biopsy Device - designed with both optimal biopsy sample quality and user ergonomics in mind.